{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from Bio import Entrez\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "# Definir o e-mail para a API do NCBI\n",
    "Entrez.email = \"...@gmail.com\"\n",
    "\n",
    "def search_pubmed(query, max_results=10):\n",
    "    # Realiza a pesquisa no PubMed\n",
    "    handle = Entrez.esearch(db=\"pubmed\", term=query, retmax=max_results)\n",
    "    record = Entrez.read(handle)\n",
    "    handle.close()\n",
    "    return record[\"IdList\"]\n",
    "\n",
    "def fetch_pubmed_articles(article_ids):\n",
    "    # Obtem os registros dos artigos\n",
    "    handle = Entrez.efetch(db=\"pubmed\", id=article_ids, rettype=\"medline\", retmode=\"text\")\n",
    "    records = handle.read()\n",
    "    handle.close()\n",
    "    return records\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "PMID- 38063339\n",
      "OWN - NLM\n",
      "STAT- Publisher\n",
      "LR  - 20231208\n",
      "IS  - 1741-7899 (Electronic)\n",
      "IS  - 1470-1626 (Linking)\n",
      "DP  - 2023 Dec 1\n",
      "TI  - MicroRNA-146b negatively affects bovine embryo development and quality.\n",
      "LID - REP-23-0155 [pii]\n",
      "LID - 10.1530/REP-23-0155 [doi]\n",
      "AB  - MicroRNAs (miRNAs), which can be carried inside extracellular vesicles (EVs), \n",
      "      play a crucial role in regulating embryo development up to the blastocyst stage. \n",
      "      Yet, the molecular mechanisms underlying blastocyst development and quality are \n",
      "      largely unknown. Recently, our group identified 69 differentially expressed \n",
      "      miRNAs in extracellular vesicles (EVs) isolated from culture medium conditioned \n",
      "      by bovine embryos that either developed to the blastocyst stage or did not \n",
      "      (non-blastocysts). We found miR-146b to be more abundant in the EVs derived from \n",
      "      media conditioned by non-blastocyst embryos. Using RT-qPCR, we here confirmed the \n",
      "      upregulation of miR-146b in non-blastocyst (arrested at 2-4 cell and morula \n",
      "      stage) embryos compared to blastocysts (p<0.005), which coincides with the \n",
      "      upregulation of miR-146b in EVs derived from the medium of these non-blastocysts. \n",
      "      To evaluate a functional effect, bovine embryo culture media were supplemented \n",
      "      with miR-146b mimics, resulting in significantly decreased embryo quality, with \n",
      "      lower blastocyst rates at day 7 and lower total cell numbers, while the opposite \n",
      "      was found after supplementation with miR-146b inhibitors, which resulted in \n",
      "      reduced apoptosis rates (P < 0.01). Transcriptomic analysis of embryos treated \n",
      "      with miR-146b mimics or inhibitors showed differential expression (P < 0.01) of \n",
      "      genes associated with apoptosis, cell differentiation, and the RNA Pol II \n",
      "      transcription complex, including WDR36, MBNL2, ERCC6l2, PYGO1, and SNIP1. \n",
      "      Overall, miR-146b is overexpressed in non-blastocyst embryos and in EVs secreted \n",
      "      by these embryos, and it regulates genes involved in embryo development and \n",
      "      apoptosis, resulting in decreased embryo quality.\n",
      "FAU - Pavani, Krishna Chaitanya\n",
      "AU  - Pavani KC\n",
      "AD  - K Pavani, Department of Internal Medicine, Reproduction and Population Medicine, \n",
      "      University of Ghent, Gent, Belgium.\n",
      "FAU - XueFeng, Guan\n",
      "AU  - XueFeng G\n",
      "AD  - G XueFeng, Department of Nutrition, Genetics and Ethology, Ghent University, \n",
      "      Merelbeke, Belgium.\n",
      "FAU - Chunduru, Jayendra\n",
      "AU  - Chunduru J\n",
      "AD  - J Chunduru, Department of Chemistry and Biochemistry, Texas Tech University, \n",
      "      Lubbock, United States.\n",
      "FAU - Meese, Tim\n",
      "AU  - Meese T\n",
      "AD  - T Meese, Department of Pharmaceutics, Ghent University, Gent, Belgium.\n",
      "FAU - Peelman, Luc J\n",
      "AU  - Peelman LJ\n",
      "AD  - L Peelman, Nutrition, Genetics and Ethology, Ghent University, Gent, Belgium.\n",
      "FAU - Van Nieuwerburgh, Filip\n",
      "AU  - Van Nieuwerburgh F\n",
      "AD  - F Van Nieuwerburgh, Department of Pharmaceutics, Ghent University, Gent, Belgium.\n",
      "FAU - Deforce, Dieter\n",
      "AU  - Deforce D\n",
      "AD  - D Deforce, Department of Pharmaceutics, Ghent University, Gent, Belgium.\n",
      "FAU - Hendrix, An\n",
      "AU  - Hendrix A\n",
      "AD  - A Hendrix, Department of Human Structure and Repair, University Hospital Ghent, \n",
      "      Gent, Belgium.\n",
      "FAU - Tilleman, Kelly\n",
      "AU  - Tilleman K\n",
      "AD  - K Tilleman, Reproductive Medicine, University Hospital Ghent, Gent, Belgium.\n",
      "FAU - Van Soom, Ann\n",
      "AU  - Van Soom A\n",
      "AD  - A Van Soom, Department of Internal Medicine, Reproduction and Population \n",
      "      Medicine, Ghent University, Merelbeke, Belgium.\n",
      "FAU - Smits, Katrien\n",
      "AU  - Smits K\n",
      "AD  - K Smits, Department of Internal Medicine, Reproduction and Population Medicine, \n",
      "      University of Ghent, Gent, Belgium.\n",
      "LA  - eng\n",
      "PT  - Journal Article\n",
      "DEP - 20231201\n",
      "PL  - England\n",
      "TA  - Reproduction\n",
      "JT  - Reproduction (Cambridge, England)\n",
      "JID - 100966036\n",
      "SB  - IM\n",
      "EDAT- 2023/12/08 12:42\n",
      "MHDA- 2023/12/08 12:42\n",
      "CRDT- 2023/12/08 08:23\n",
      "PHST- 2023/04/25 00:00 [received]\n",
      "PHST- 2023/12/08 00:00 [accepted]\n",
      "PHST- 2023/12/08 12:42 [medline]\n",
      "PHST- 2023/12/08 12:42 [pubmed]\n",
      "PHST- 2023/12/08 08:23 [entrez]\n",
      "AID - REP-23-0155 [pii]\n",
      "AID - 10.1530/REP-23-0155 [doi]\n",
      "PST - aheadofprint\n",
      "SO  - Reproduction. 2023 Dec 1:REP-23-0155. doi: 10.1530/REP-23-0155.\n",
      "\n",
      "PMID- 36459010\n",
      "OWN - NLM\n",
      "STAT- MEDLINE\n",
      "DCOM- 20221206\n",
      "LR  - 20221216\n",
      "IS  - 2284-0729 (Electronic)\n",
      "IS  - 1128-3602 (Linking)\n",
      "VI  - 26\n",
      "IP  - 22\n",
      "DP  - 2022 Nov\n",
      "TI  - Molecular mechanism of Tongmai Yangxin Pill intervention in elderly patients with \n",
      "      coronary heart disease.\n",
      "PG  - 8265-8275\n",
      "LID - 30359 [pii]\n",
      "LID - 10.26355/eurrev_202211_30359 [doi]\n",
      "AB  - OBJECTIVE: The Tongmai Yangxin Pill (TMYX) is considered an effective treatment \n",
      "      for coronary heart disease (CHD). However, its mechanism is unclear. This study \n",
      "      aimed at exploring the molecular mechanisms and key genes of the TMYX in the \n",
      "      treatment of CHD. MATERIALS AND METHODS: Differentially expressed genes (DEGs) in \n",
      "      the GSE142008 dataset were screened with the R software, and Gene Ontology (GO) \n",
      "      and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were \n",
      "      performed. Then, protein-protein interactions were analyzed using the Search Tool \n",
      "      for the Retrieval of Interacting Genes database. The correlation analysis between \n",
      "      key genes was conducted, and gene expression was verified. RESULTS: A total of \n",
      "      1,614 DEGs were identified, including 1,591 upregulated and 23 downregulated \n",
      "      genes. GO enrichment analysis revealed that 240 biological processes, 44 cellular \n",
      "      components, and 23 molecular functions were significantly enriched for DEGs in \n",
      "      elderly patients with CHD. Similarly, 36 KEGG terms were significantly enriched \n",
      "      for DEGs. Ten key genes were screened, and after verification and analysis, seven \n",
      "      key genes (RSL24D1, NMD3, DCAF13, WDR36, SDAD1, KRR1, and RPF1) were identified \n",
      "      as significantly overexpressed. CONCLUSIONS: We identified seven key genes as \n",
      "      candidate biomarkers for TMYX in the treatment of elderly patients with CHD; \n",
      "      these results can serve as a theoretical basis for targeted therapy.\n",
      "FAU - Xiao, Z-W\n",
      "AU  - Xiao ZW\n",
      "AD  - Department of Food and Drug Engineering, School of Pharmacy, Key Laboratory of \n",
      "      Hunan Province for Prevention and Treatment of Integrated Traditional Chinese and \n",
      "      Western Medicine on Cardiocerebral Diseases, School of Nursing, School of \n",
      "      Informatics, Hunan University of Chinese Medicine, Hunan, Changsh, P.R. China. \n",
      "      479157643@qq.com.\n",
      "FAU - Liu, Y\n",
      "AU  - Liu Y\n",
      "FAU - Li, Z-Y\n",
      "AU  - Li ZY\n",
      "FAU - Li, S\n",
      "AU  - Li S\n",
      "FAU - Qin, L-H\n",
      "AU  - Qin LH\n",
      "LA  - eng\n",
      "PT  - Journal Article\n",
      "PL  - Italy\n",
      "TA  - Eur Rev Med Pharmacol Sci\n",
      "JT  - European review for medical and pharmacological sciences\n",
      "JID - 9717360\n",
      "RN  - 0 (NMD3 protein, human)\n",
      "RN  - 0 (RNA-Binding Proteins)\n",
      "SB  - IM\n",
      "MH  - Aged\n",
      "MH  - Humans\n",
      "MH  - *Patients\n",
      "MH  - *Coronary Disease/drug therapy/genetics\n",
      "MH  - Gene Ontology\n",
      "MH  - Probability\n",
      "MH  - Search Engine\n",
      "MH  - RNA-Binding Proteins\n",
      "EDAT- 2022/12/03 06:00\n",
      "MHDA- 2022/12/07 06:00\n",
      "CRDT- 2022/12/02 10:08\n",
      "PHST- 2022/12/02 10:08 [entrez]\n",
      "PHST- 2022/12/03 06:00 [pubmed]\n",
      "PHST- 2022/12/07 06:00 [medline]\n",
      "AID - 30359 [pii]\n",
      "AID - 10.26355/eurrev_202211_30359 [doi]\n",
      "PST - ppublish\n",
      "SO  - Eur Rev Med Pharmacol Sci. 2022 Nov;26(22):8265-8275. doi: \n",
      "      10.26355/eurrev_202211_30359.\n",
      "\n",
      "PMID- 35937980\n",
      "OWN - NLM\n",
      "STAT- PubMed-not-MEDLINE\n",
      "LR  - 20220809\n",
      "IS  - 1664-8021 (Print)\n",
      "IS  - 1664-8021 (Electronic)\n",
      "IS  - 1664-8021 (Linking)\n",
      "VI  - 13\n",
      "DP  - 2022\n",
      "TI  - WDR36 Safeguards Self-Renewal and Pluripotency of Human Extended Pluripotent Stem \n",
      "      Cells.\n",
      "PG  - 905395\n",
      "LID - 10.3389/fgene.2022.905395 [doi]\n",
      "LID - 905395\n",
      "AB  - Extended pluripotent stem cells (EPS cells) have unlimited self-renewal ability \n",
      "      and the potential to differentiate into mesodermal, ectodermal, and endodermal \n",
      "      cells. Notably, in addition to developing the embryonic (Em) lineages, it can \n",
      "      also make an effective contribution to extraembryonic (ExEm) lineages both in \n",
      "      vitro and in vivo. However, multiple mysteries still remain about the underlying \n",
      "      molecular mechanism of EPS cells' maintenance and developmental potential. WDR36 \n",
      "      (WD Repeat Domain 36), a protein of 105 kDa with 14 WD40 repeats, which may fold \n",
      "      into two beta-propellers, participates in 18sRNA synthesis and P53 stress response. \n",
      "      Though WDR36 safeguards mouse early embryonic development, that is, homozygous \n",
      "      knockout of WDR36 can result in embryonic lethality, what role does WDR36 plays \n",
      "      in self-renewal and differentiation developmental potential of human EPS cells is \n",
      "      still a subject of concern. Here, our findings suggested that the expression of \n",
      "      WDR36 was downregulated during human hEPS cells lost self-renewal. Through \n",
      "      constructing inducible knockdown or overexpressing WDR36-human EPS cell lines, we \n",
      "      found that WDR36 knockdown disrupted self-renewal but promoted the mesodermal \n",
      "      differentiation of human EPS cells; however, overexpressing of WDR36 had little \n",
      "      effect. Additionally, P53 inhibition could reverse the effects of WDR36 \n",
      "      knockdown, on both self-renewal maintenance and differentiation potential of \n",
      "      human EPS cells. These data implied that WDR36 safeguards self-renewal and \n",
      "      pluripotency of human EPS cells, which would extend our understanding of the \n",
      "      molecular mechanisms of human EPS cells' self-renewal and differentiation.\n",
      "CI  - Copyright (c) 2022 An, Yao, Zhang, Sun, Yu, Jia and Yang.\n",
      "FAU - An, Shiyu\n",
      "AU  - An S\n",
      "AD  - State Key Laboratory of Reproductive Medicine, Nanjing Medical University, \n",
      "      Nanjing, China.\n",
      "FAU - Yao, Dan\n",
      "AU  - Yao D\n",
      "AD  - Department of Obstetrics, Women's Hospital of Nanjing Medical University, Nanjing \n",
      "      Maternity and Child Health Care Institute, Nanjing, China.\n",
      "AD  - Fourth Clinical Medicine College, Nanjing Medical University, Nanjing, China.\n",
      "FAU - Zhang, Wenyi\n",
      "AU  - Zhang W\n",
      "AD  - State Key Laboratory of Reproductive Medicine, Nanjing Medical University, \n",
      "      Nanjing, China.\n",
      "FAU - Sun, Hao\n",
      "AU  - Sun H\n",
      "AD  - State Key Laboratory of Reproductive Medicine, Nanjing Medical University, \n",
      "      Nanjing, China.\n",
      "FAU - Yu, Tianyi\n",
      "AU  - Yu T\n",
      "AD  - Department of Gynecology and Obstetrics, Affiliated Zhongda Hospital, Medical \n",
      "      School, Southeast University, Nanjing, China.\n",
      "FAU - Jia, Ruizhe\n",
      "AU  - Jia R\n",
      "AD  - Department of Obstetrics, Women's Hospital of Nanjing Medical University, Nanjing \n",
      "      Maternity and Child Health Care Institute, Nanjing, China.\n",
      "FAU - Yang, Yang\n",
      "AU  - Yang Y\n",
      "AD  - State Key Laboratory of Reproductive Medicine, Nanjing Medical University, \n",
      "      Nanjing, China.\n",
      "LA  - eng\n",
      "PT  - Journal Article\n",
      "DEP - 20220722\n",
      "PL  - Switzerland\n",
      "TA  - Front Genet\n",
      "JT  - Frontiers in genetics\n",
      "JID - 101560621\n",
      "PMC - PMC9353684\n",
      "OTO - NOTNLM\n",
      "OT  - WDR36\n",
      "OT  - differentiation\n",
      "OT  - hEPS cells\n",
      "OT  - p53\n",
      "OT  - self-renewal\n",
      "COIS- The authors declare that the research was conducted in the absence of any \n",
      "      commercial or financial relationships that could be construed as a potential \n",
      "      conflict of interest.\n",
      "EDAT- 2022/08/09 06:00\n",
      "MHDA- 2022/08/09 06:01\n",
      "CRDT- 2022/08/08 04:11\n",
      "PHST- 2022/03/27 00:00 [received]\n",
      "PHST- 2022/05/30 00:00 [accepted]\n",
      "PHST- 2022/08/08 04:11 [entrez]\n",
      "PHST- 2022/08/09 06:00 [pubmed]\n",
      "PHST- 2022/08/09 06:01 [medline]\n",
      "AID - 905395 [pii]\n",
      "AID - 10.3389/fgene.2022.905395 [doi]\n",
      "PST - epublish\n",
      "SO  - Front Genet. 2022 Jul 22;13:905395. doi: 10.3389/fgene.2022.905395. eCollection \n",
      "      2022.\n",
      "\n",
      "PMID- 34681019\n",
      "OWN - NLM\n",
      "STAT- MEDLINE\n",
      "DCOM- 20220208\n",
      "LR  - 20220512\n",
      "IS  - 2073-4425 (Electronic)\n",
      "IS  - 2073-4425 (Linking)\n",
      "VI  - 12\n",
      "IP  - 10\n",
      "DP  - 2021 Oct 15\n",
      "TI  - WDR36-Associated Neurodegeneration: A Case Report Highlights Possible Mechanisms \n",
      "      of Normal Tension Glaucoma.\n",
      "LID - 10.3390/genes12101624 [doi]\n",
      "LID - 1624\n",
      "AB  - WDR36 is one of a number of genes implicated in the pathogenesis of adult-onset \n",
      "      primary open angle glaucoma (POAG). Here we describe in detail the phenotype of a \n",
      "      patient with pathogenic variation in WDR36 who presented with a protracted \n",
      "      history of central vision loss. On exam visual acuities were at 20/100 level, had \n",
      "      a tritan color defect and showed central arcuate visual field defects on visual \n",
      "      field testing. Enlarged cup-to-disk ratios with normal intraocular pressures were \n",
      "      associated with severe thinning of the ganglion cell layer (GCL) and retinal \n",
      "      nerve fiber layer consistent with a clinical diagnosis of normal tension \n",
      "      glaucoma. Full-field electroretinograms revealed a severe inner retinal \n",
      "      dysfunction with reduced amplitudes and remarkably delayed timings of the b-wave, \n",
      "      but preserved photoreceptor (a-wave) function. The pattern described herein \n",
      "      recapitulates some of the findings of an animal model of WDR36-associated POAG \n",
      "      and suggests a mechanism of disease that involves a retina-wide inner retinal \n",
      "      dysfunction and neurodegeneration beyond the GCL. Further detailed structural and \n",
      "      functional characterizations of patients with a pathogenic variant in the WDR36 \n",
      "      gene are required to confirm these findings.\n",
      "FAU - Meer, Elana\n",
      "AU  - Meer E\n",
      "AD  - Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA 19104, \n",
      "      USA.\n",
      "FAU - Aleman, Tomas S\n",
      "AU  - Aleman TS\n",
      "AD  - Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA 19104, \n",
      "      USA.\n",
      "AD  - FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of \n",
      "      Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.\n",
      "FAU - Ross, Ahmara G\n",
      "AU  - Ross AG\n",
      "AD  - Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA 19104, \n",
      "      USA.\n",
      "AD  - FM Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of \n",
      "      Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.\n",
      "LA  - eng\n",
      "GR  - K08 EY030163/EY/NEI NIH HHS/United States\n",
      "GR  - K08-EY-030163-03/EY/NEI NIH HHS/United States\n",
      "PT  - Case Reports\n",
      "PT  - Research Support, N.I.H., Extramural\n",
      "DEP - 20211015\n",
      "PL  - Switzerland\n",
      "TA  - Genes (Basel)\n",
      "JT  - Genes\n",
      "JID - 101551097\n",
      "RN  - 0 (Eye Proteins)\n",
      "RN  - 0 (WDR36 protein, human)\n",
      "SB  - IM\n",
      "MH  - Aged\n",
      "MH  - Eye Proteins/*genetics\n",
      "MH  - *Genetic Predisposition to Disease\n",
      "MH  - Glaucoma, Open-Angle/diagnostic imaging/*genetics/physiopathology\n",
      "MH  - Humans\n",
      "MH  - Intraocular Pressure/genetics\n",
      "MH  - Low Tension Glaucoma/diagnostic imaging/*genetics/physiopathology\n",
      "MH  - Male\n",
      "MH  - Phenotype\n",
      "MH  - Retina/diagnostic imaging/metabolism/pathology\n",
      "MH  - Retinal Ganglion Cells/pathology\n",
      "MH  - Visual Field Tests\n",
      "PMC - PMC8536154\n",
      "OTO - NOTNLM\n",
      "OT  - WDR36\n",
      "OT  - ganglion cell layer\n",
      "OT  - low tension glaucoma\n",
      "COIS- The authors declare no conflict of interest.\n",
      "EDAT- 2021/10/24 06:00\n",
      "MHDA- 2022/02/09 06:00\n",
      "CRDT- 2021/10/23 01:06\n",
      "PHST- 2021/09/02 00:00 [received]\n",
      "PHST- 2021/09/30 00:00 [revised]\n",
      "PHST- 2021/10/12 00:00 [accepted]\n",
      "PHST- 2021/10/23 01:06 [entrez]\n",
      "PHST- 2021/10/24 06:00 [pubmed]\n",
      "PHST- 2022/02/09 06:00 [medline]\n",
      "AID - genes12101624 [pii]\n",
      "AID - genes-12-01624 [pii]\n",
      "AID - 10.3390/genes12101624 [doi]\n",
      "PST - epublish\n",
      "SO  - Genes (Basel). 2021 Oct 15;12(10):1624. doi: 10.3390/genes12101624.\n",
      "\n",
      "PMID- 33641569\n",
      "OWN - NLM\n",
      "STAT- MEDLINE\n",
      "DCOM- 20220426\n",
      "LR  - 20220614\n",
      "IS  - 1744-5086 (Electronic)\n",
      "IS  - 0928-6586 (Linking)\n",
      "VI  - 29\n",
      "IP  - 1\n",
      "DP  - 2022 Feb\n",
      "TI  - Genetic Epidemiology of Primary Congenital Glaucoma in the 22 Arab Countries: A \n",
      "      Systematic Review.\n",
      "PG  - 1-12\n",
      "LID - 10.1080/09286586.2021.1883676 [doi]\n",
      "AB  - PURPOSE: Primary congenital glaucoma (PCG) is a rare glaucoma type that develops \n",
      "      in early infantile period and contributes to an elevated pressure on ocular \n",
      "      cavity. Variants in CYP1B1 gene are the most encountered in PCG cases. The \n",
      "      prevalence of PCG is relatively high among Arabs, however its genetic \n",
      "      epidemiology remains understudied. This study aims to systematically identify all \n",
      "      reported PCG disease-causing variants in the Arab population and investigate \n",
      "      their potential genotype-phenotype correlations. METHODS: We searched four \n",
      "      different databases (PubMed, ScienceDirect, Google Scholar, and Scopus) from the \n",
      "      time of inception until July 2020. Broad search terms were used to capture all \n",
      "      possible information about the genetic epidemiology of PCG among Arabs. RESULTS: \n",
      "      We identified a total of 77 disease-causing variants in 361 patients and 88 \n",
      "      families; of these, 33 were unique to Arabs. Sixty-nine variants were identified \n",
      "      in the CYP1B1 gene, five variants were in the MYOC gene and single variants were \n",
      "      reported in NTF4, FOXC1, and WDR36 genes. The most common reported variant was \n",
      "      the c.182 G > A in the CYP1B1 gene. All identified variants were from ten Arab \n",
      "      Countries (Saudi Arabia, Kuwait, Oman, Egypt, Morocco, Lebanon, Tunisia, Iraq, \n",
      "      Algeria, and Mauritania). We identified 44 shared variants with other ethnicities \n",
      "      demonstrated a distinctive genotype-phenotype correlation. Consanguinity was \n",
      "      observed in the majority of Arab PCG patients, ranging from 45% to 100%. \n",
      "      CONCLUSION: PCG causing variants were identified in 10 Arab countries, which were \n",
      "      mostly detected in the CYB1P1 gene. Arab patients with PCG seem to have \n",
      "      distinctive genotype-phenotype correlations.\n",
      "FAU - Jemmeih, Sara\n",
      "AU  - Jemmeih S\n",
      "AD  - Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar \n",
      "      University, Doha. Qatar.\n",
      "FAU - Malik, Shaza\n",
      "AU  - Malik S\n",
      "AD  - Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar \n",
      "      University, Doha. Qatar.\n",
      "FAU - Okashah, Sarah\n",
      "AU  - Okashah S\n",
      "AD  - Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar \n",
      "      University, Doha. Qatar.\n",
      "FAU - Zayed, Hatem\n",
      "AU  - Zayed H\n",
      "AD  - Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar \n",
      "      University, Doha. Qatar.\n",
      "LA  - eng\n",
      "PT  - Journal Article\n",
      "PT  - Review\n",
      "PT  - Systematic Review\n",
      "DEP - 20210228\n",
      "PL  - England\n",
      "TA  - Ophthalmic Epidemiol\n",
      "JT  - Ophthalmic epidemiology\n",
      "JID - 9435674\n",
      "RN  - EC 1.14.14.1 (Cytochrome P-450 CYP1B1)\n",
      "SB  - IM\n",
      "MH  - *Arabs/genetics\n",
      "MH  - Cytochrome P-450 CYP1B1/genetics\n",
      "MH  - DNA Mutational Analysis\n",
      "MH  - Genetic Association Studies\n",
      "MH  - *Glaucoma/epidemiology/genetics\n",
      "MH  - Humans\n",
      "MH  - Molecular Epidemiology\n",
      "MH  - Mutation\n",
      "OTO - NOTNLM\n",
      "OT  - Arab countries\n",
      "OT  - consanguinity\n",
      "OT  - epidemiology\n",
      "OT  - primary congenital glaucoma; variants\n",
      "EDAT- 2021/03/02 06:00\n",
      "MHDA- 2022/04/27 06:00\n",
      "CRDT- 2021/03/01 05:25\n",
      "PHST- 2021/03/02 06:00 [pubmed]\n",
      "PHST- 2022/04/27 06:00 [medline]\n",
      "PHST- 2021/03/01 05:25 [entrez]\n",
      "AID - 10.1080/09286586.2021.1883676 [doi]\n",
      "PST - ppublish\n",
      "SO  - Ophthalmic Epidemiol. 2022 Feb;29(1):1-12. doi: 10.1080/09286586.2021.1883676. \n",
      "      Epub 2021 Feb 28.\n",
      "\n",
      "PMID- 33212090\n",
      "OWN - NLM\n",
      "STAT- MEDLINE\n",
      "DCOM- 20220128\n",
      "LR  - 20221207\n",
      "IS  - 1600-0641 (Electronic)\n",
      "IS  - 0168-8278 (Linking)\n",
      "VI  - 74\n",
      "IP  - 4\n",
      "DP  - 2021 Apr\n",
      "TI  - Clinicopathologic features, tumor immune microenvironment and genomic landscape \n",
      "      of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.\n",
      "PG  - 838-849\n",
      "LID - S0168-8278(20)33763-6 [pii]\n",
      "LID - 10.1016/j.jhep.2020.10.037 [doi]\n",
      "AB  - BACKGROUND & AIMS: Little is known about Epstein-Barr virus (EBV)-associated \n",
      "      intrahepatic cholangiocarcinoma (EBVaICC) because of its rarity. We aimed to \n",
      "      comprehensively investigate the clinicopathology, tumor immune microenvironment \n",
      "      (TIME) and genomic landscape of this entity in southern China. METHODS: We \n",
      "      evaluated 303 intrahepatic cholangiocarcinomas (ICCs) using in situ hybridization \n",
      "      for EBV. We compared clinicopathological parameters between EBVaICC and \n",
      "      nonEBVaICC, and we analyzed EBV infection status, tumor-infiltrating lymphocytes \n",
      "      (TILs) and genomic features of EBVaICC by immunohistochemistry, double staining, \n",
      "      nested PCR, multiplex immunofluorescence staining, fluorescence in situ \n",
      "      hybridization and whole-exome sequencing. RESULTS: EBVaICC accounted for 6.6% of \n",
      "      ICCs and was associated with EBV latency type I infection and clonal EBV \n",
      "      isolates. Patients with EBVaICC were more often female and younger, with solitary \n",
      "      tumors, higher HBV infection rates and less frequent cirrhosis; the \n",
      "      lymphoepithelioma-like (LEL) subtype was more common in EBVaICC. EBVaICC was \n",
      "      associated with a significantly larger TIME component than nonEBVaICC. The LEL \n",
      "      subtype of EBVaICC - associated with a significantly increased density and \n",
      "      proportion of CD20+ B cells and CD8+ T cells - was associated with significantly \n",
      "      higher 2-year survival rates than conventional EBVaICC and nonEBVaICC. Both PD-1 \n",
      "      and PD-L1 in TILs, and PD-L1 in tumor cells, were overexpressed in EBVaICC. High \n",
      "      PD-L1 expression in tumor cells and high CD8+ TIL densities were significantly \n",
      "      more common in EBVaICC than in nonEBVaICC. Seven genes (MUC4, DNAH1, GLI2, LIPE, \n",
      "      MYH7, RP11-766F14.2 and WDR36) were mutated in at least 3 patients. EBVaICC had a \n",
      "      different mutational pattern to liver fluke-associated cholangiocarcinoma and \n",
      "      HBV-associated ICC. CONCLUSIONS: EBVaICC, as a subset of ICC, has unique \n",
      "      etiological, clinicopathological and genetic characteristics, with a \n",
      "      significantly larger TIME component. Paradoxically, patients with EBVaICC could \n",
      "      be candidates for immune checkpoint therapy. LAY SUMMARY: Epstein-Barr virus \n",
      "      (EBV) is associated with a subtype of intrahepatic cholangiocarcinoma, with \n",
      "      unique clinicopathological and genetic characteristics. The tumor immune \n",
      "      microenvironment is also different in this tumor subtype and patients with \n",
      "      EBV-associated intrahepatic cholangiocarcinoma may respond well to immune \n",
      "      checkpoint inhibitors.\n",
      "CI  - Copyright (c) 2020 European Association for the Study of the Liver. Published by \n",
      "      Elsevier B.V. All rights reserved.\n",
      "FAU - Huang, Yu-Hua\n",
      "AU  - Huang YH\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer \n",
      "      Center, Guangzhou, Guangdong, 510060, China.\n",
      "FAU - Zhang, Chris Zhi-Yi\n",
      "AU  - Zhang CZ\n",
      "AD  - MOE Key Laboratory of Tumor Molecular Biology and Key Laboratory of Functional \n",
      "      Protein Research of Guangdong Higher Education Institutes, Institute of Life and \n",
      "      Health Engineering, College of Life Science and Technology, Jinan University, \n",
      "      Guangzhou, 510632, China.\n",
      "FAU - Huang, Qun-Sheng\n",
      "AU  - Huang QS\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer \n",
      "      Center, Guangzhou, Guangdong, 510060, China.\n",
      "FAU - Yeong, Joe\n",
      "AU  - Yeong J\n",
      "AD  - Department of Anatomical Pathology, Singapore General Hospital, Singapore, \n",
      "      169856, Singapore; Institute of Molecular Cell Biology (IMCB), Agency of Science, \n",
      "      Technology and Research (A *STAR), Singapore, 169856, Singapore; Singapore \n",
      "      Immunology Network, Agency of Science (SIgN), Technology and Research (A *STAR), \n",
      "      Singapore, 169856, Singapore.\n",
      "FAU - Wang, Fang\n",
      "AU  - Wang F\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China; Department of Molecular Diagnosis, Sun Yat-sen \n",
      "      University Cancer Center, Guangzhou, Guangdong 510060, China.\n",
      "FAU - Yang, Xia\n",
      "AU  - Yang X\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer \n",
      "      Center, Guangzhou, Guangdong, 510060, China.\n",
      "FAU - He, Yang-Fan\n",
      "AU  - He YF\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer \n",
      "      Center, Guangzhou, Guangdong, 510060, China.\n",
      "FAU - Zhang, Xiao-Long\n",
      "AU  - Zhang XL\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China.\n",
      "FAU - Zhang, Hua\n",
      "AU  - Zhang H\n",
      "AD  - Center for Infection and Immunity Study, School of Medicine, Sun Yat-sen \n",
      "      University, Guangzhou, China.\n",
      "FAU - Chen, Shi-Lu\n",
      "AU  - Chen SL\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer \n",
      "      Center, Guangzhou, Guangdong, 510060, China.\n",
      "FAU - Zheng, Yin-Li\n",
      "AU  - Zheng YL\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer \n",
      "      Center, Guangzhou, Guangdong, 510060, China.\n",
      "FAU - Deng, Ru\n",
      "AU  - Deng R\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer \n",
      "      Center, Guangzhou, Guangdong, 510060, China.\n",
      "FAU - Lin, Cen-Shan\n",
      "AU  - Lin CS\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer \n",
      "      Center, Guangzhou, Guangdong, 510060, China.\n",
      "FAU - Yang, Ming-Ming\n",
      "AU  - Yang MM\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer \n",
      "      Center, Guangzhou, Guangdong, 510060, China.\n",
      "FAU - Li, Yan\n",
      "AU  - Li Y\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer \n",
      "      Center, Guangzhou, Guangdong, 510060, China.\n",
      "FAU - Jiang, Chen\n",
      "AU  - Jiang C\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer \n",
      "      Center, Guangzhou, Guangdong, 510060, China.\n",
      "FAU - Kin-Wah Lee, Terence\n",
      "AU  - Kin-Wah Lee T\n",
      "AD  - Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic \n",
      "      University, Hong Kong.\n",
      "FAU - Ma, Stephanie\n",
      "AU  - Ma S\n",
      "AD  - School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of \n",
      "      Hong Kong, Hong Kong.\n",
      "FAU - Zeng, Mu-Sheng\n",
      "AU  - Zeng MS\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China.\n",
      "FAU - Yun, Jing-Ping\n",
      "AU  - Yun JP\n",
      "AD  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in \n",
      "      Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, \n",
      "      Guangdong, 510060, China; Department of Pathology, Sun Yat-sen University Cancer \n",
      "      Center, Guangzhou, Guangdong, 510060, China. Electronic address: \n",
      "      yunjp@sysucc.org.cn.\n",
      "LA  - eng\n",
      "PT  - Journal Article\n",
      "PT  - Research Support, Non-U.S. Gov't\n",
      "DEP - 20201117\n",
      "PL  - Netherlands\n",
      "TA  - J Hepatol\n",
      "JT  - Journal of hepatology\n",
      "JID - 8503886\n",
      "RN  - 0 (B7-H1 Antigen)\n",
      "RN  - 0 (CD274 protein, human)\n",
      "RN  - 0 (Immune Checkpoint Inhibitors)\n",
      "RN  - 0 (PDCD1 protein, human)\n",
      "RN  - 0 (Programmed Cell Death 1 Receptor)\n",
      "SB  - IM\n",
      "MH  - B7-H1 Antigen/*genetics\n",
      "MH  - *Bile Duct Neoplasms/genetics/mortality/pathology/therapy\n",
      "MH  - CD8-Positive T-Lymphocytes/pathology\n",
      "MH  - China/epidemiology\n",
      "MH  - *Cholangiocarcinoma/genetics/mortality/pathology/therapy\n",
      "MH  - *Epstein-Barr Virus Infections/complications/diagnosis/epidemiology\n",
      "MH  - Female\n",
      "MH  - *Herpesvirus 4, Human/genetics/isolation & purification\n",
      "MH  - Humans\n",
      "MH  - *Immune Checkpoint Inhibitors/immunology/therapeutic use\n",
      "MH  - Immunohistochemistry\n",
      "MH  - Lymphocytes, Tumor-Infiltrating/immunology\n",
      "MH  - Male\n",
      "MH  - Middle Aged\n",
      "MH  - Prognosis\n",
      "MH  - Programmed Cell Death 1 Receptor/*genetics\n",
      "MH  - Survival Analysis\n",
      "MH  - Tumor Microenvironment/*immunology\n",
      "MH  - Exome Sequencing/methods\n",
      "OTO - NOTNLM\n",
      "OT  - Clinicopathology\n",
      "OT  - Epstein-Barr virus\n",
      "OT  - Genomic landscape\n",
      "OT  - Intrahepatic cholangiocarcinoma\n",
      "OT  - Tumor immune microenvironment\n",
      "COIS- Conflicts of interest The authors declare no conflicts of interest that pertain \n",
      "      to this work. Please refer to the accompanying ICMJE disclosure forms for further \n",
      "      details.\n",
      "EDAT- 2020/11/20 06:00\n",
      "MHDA- 2022/01/29 06:00\n",
      "CRDT- 2020/11/19 20:08\n",
      "PHST- 2020/05/13 00:00 [received]\n",
      "PHST- 2020/10/07 00:00 [revised]\n",
      "PHST- 2020/10/30 00:00 [accepted]\n",
      "PHST- 2020/11/20 06:00 [pubmed]\n",
      "PHST- 2022/01/29 06:00 [medline]\n",
      "PHST- 2020/11/19 20:08 [entrez]\n",
      "AID - S0168-8278(20)33763-6 [pii]\n",
      "AID - 10.1016/j.jhep.2020.10.037 [doi]\n",
      "PST - ppublish\n",
      "SO  - J Hepatol. 2021 Apr;74(4):838-849. doi: 10.1016/j.jhep.2020.10.037. Epub 2020 Nov \n",
      "      17.\n",
      "\n",
      "PMID- 32545285\n",
      "OWN - NLM\n",
      "STAT- MEDLINE\n",
      "DCOM- 20210325\n",
      "LR  - 20211204\n",
      "IS  - 1422-0067 (Electronic)\n",
      "IS  - 1422-0067 (Linking)\n",
      "VI  - 21\n",
      "IP  - 11\n",
      "DP  - 2020 Jun 11\n",
      "TI  - The Genetic and Endoplasmic Reticulum-Mediated Molecular Mechanisms of Primary \n",
      "      Open-Angle Glaucoma.\n",
      "LID - 10.3390/ijms21114171 [doi]\n",
      "LID - 4171\n",
      "AB  - Glaucoma is a heterogenous, chronic, progressive group of eye diseases, which \n",
      "      results in irreversible loss of vision. There are several types of glaucoma, \n",
      "      whereas the primary open-angle glaucoma (POAG) constitutes the most common type \n",
      "      of glaucoma, accounting for three-quarters of all glaucoma cases. The \n",
      "      pathological mechanisms leading to POAG pathogenesis are multifactorial and still \n",
      "      poorly understood, but it is commonly known that significantly elevated \n",
      "      intraocular pressure (IOP) plays a crucial role in POAG pathogenesis. Besides, \n",
      "      genetic predisposition and aggregation of abrogated proteins within the \n",
      "      endoplasmic reticulum (ER) lumen and subsequent activation of the protein kinase \n",
      "      RNA-like endoplasmic reticulum kinase (PERK)-dependent unfolded protein response \n",
      "      (UPR) signaling pathway may also constitute important factors for POAG \n",
      "      pathogenesis at the molecular level. Glaucoma is commonly known as a 'silent \n",
      "      thief of sight', as it remains asymptomatic until later stages, and thus its \n",
      "      diagnosis is frequently delayed. Thereby, detailed knowledge about the glaucoma \n",
      "      pathophysiology is necessary to develop both biochemical and genetic tests to \n",
      "      improve its early diagnosis as well as develop a novel, ground-breaking treatment \n",
      "      strategy, as currently used medical therapies against glaucoma are limited and \n",
      "      may evoke numerous adverse side-effects in patients.\n",
      "FAU - Rozpedek-Kaminska, Wioletta\n",
      "AU  - Rozpedek-Kaminska W\n",
      "AUID- ORCID: 0000-0001-9206-1203\n",
      "AD  - Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, \n",
      "      90-419 Lodz, Poland.\n",
      "FAU - Wojtczak, Radoslaw\n",
      "AU  - Wojtczak R\n",
      "AD  - Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, \n",
      "      90-419 Lodz, Poland.\n",
      "FAU - Szaflik, Jacek P\n",
      "AU  - Szaflik JP\n",
      "AD  - Department of Ophthalmology, SPKSO Ophthalmic Hospital, Medical University of \n",
      "      Warsaw, 03-709 Warsaw, Poland.\n",
      "FAU - Szaflik, Jerzy\n",
      "AU  - Szaflik J\n",
      "AD  - Laser Eye Microsurgery Center, Clinic of Jerzy Szaflik, 00-215 Warsaw, Poland.\n",
      "FAU - Majsterek, Ireneusz\n",
      "AU  - Majsterek I\n",
      "AD  - Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, \n",
      "      90-419 Lodz, Poland.\n",
      "LA  - eng\n",
      "GR  - 2016/21/B/NZ5/01411/Narodowe Centrum Nauki/\n",
      "GR  - 2017/27/B/NZ7/02527/Narodowe Centrum Nauki/\n",
      "GR  - 2015/19/N/NZ3/00055/Narodowe Centrum Nauki/\n",
      "GR  - 502-03/5-108-05/502-54-224-18/Uniwersytet Medyczny w Lodzi/\n",
      "PT  - Journal Article\n",
      "PT  - Review\n",
      "DEP - 20200611\n",
      "PL  - Switzerland\n",
      "TA  - Int J Mol Sci\n",
      "JT  - International journal of molecular sciences\n",
      "JID - 101092791\n",
      "RN  - 0 (Cell Cycle Proteins)\n",
      "RN  - 0 (Cytoskeletal Proteins)\n",
      "RN  - 0 (Eye Proteins)\n",
      "RN  - 0 (Glycoproteins)\n",
      "RN  - 0 (Membrane Transport Proteins)\n",
      "RN  - 0 (OPTN protein, human)\n",
      "RN  - 0 (WDR36 protein, human)\n",
      "RN  - 0 (trabecular meshwork-induced glucocorticoid response protein)\n",
      "RN  - EC 2.7.11.1 (Protein Serine-Threonine Kinases)\n",
      "RN  - EC 2.7.11.1 (TBK1 protein, human)\n",
      "SB  - IM\n",
      "MH  - Cell Cycle Proteins/genetics\n",
      "MH  - Cytoskeletal Proteins/genetics\n",
      "MH  - Endoplasmic Reticulum/genetics/metabolism/*pathology\n",
      "MH  - Endoplasmic Reticulum Stress/genetics\n",
      "MH  - Eye Proteins/genetics\n",
      "MH  - Genetic Predisposition to Disease\n",
      "MH  - Glaucoma, Angle-Closure/pathology\n",
      "MH  - Glaucoma, Open-Angle/*genetics/metabolism/*pathology\n",
      "MH  - Glycoproteins/genetics\n",
      "MH  - Humans\n",
      "MH  - Membrane Transport Proteins/genetics\n",
      "MH  - Protein Serine-Threonine Kinases/genetics\n",
      "MH  - Unfolded Protein Response\n",
      "PMC - PMC7312987\n",
      "OTO - NOTNLM\n",
      "OT  - PERK\n",
      "OT  - cell death\n",
      "OT  - eye disease\n",
      "OT  - glaucoma\n",
      "OT  - hereditary\n",
      "OT  - intraocular pressure\n",
      "OT  - molecular pathologies\n",
      "OT  - ocular hypertension\n",
      "OT  - unfolded protein response\n",
      "COIS- The authors declare no conflict of interest.\n",
      "EDAT- 2020/06/18 06:00\n",
      "MHDA- 2021/03/26 06:00\n",
      "CRDT- 2020/06/18 06:00\n",
      "PHST- 2020/04/27 00:00 [received]\n",
      "PHST- 2020/06/04 00:00 [revised]\n",
      "PHST- 2020/06/09 00:00 [accepted]\n",
      "PHST- 2020/06/18 06:00 [entrez]\n",
      "PHST- 2020/06/18 06:00 [pubmed]\n",
      "PHST- 2021/03/26 06:00 [medline]\n",
      "AID - ijms21114171 [pii]\n",
      "AID - ijms-21-04171 [pii]\n",
      "AID - 10.3390/ijms21114171 [doi]\n",
      "PST - epublish\n",
      "SO  - Int J Mol Sci. 2020 Jun 11;21(11):4171. doi: 10.3390/ijms21114171.\n",
      "\n",
      "PMID- 32298610\n",
      "OWN - NLM\n",
      "STAT- MEDLINE\n",
      "DCOM- 20210921\n",
      "LR  - 20210921\n",
      "IS  - 1557-8666 (Electronic)\n",
      "IS  - 1066-5277 (Linking)\n",
      "VI  - 27\n",
      "IP  - 10\n",
      "DP  - 2020 Oct\n",
      "TI  - Identification of Biomarkers Related to Systemic Sclerosis With or Without \n",
      "      Pulmonary Hypertension Using Co-expression Analysis.\n",
      "PG  - 1519-1531\n",
      "LID - 10.1089/cmb.2019.0492 [doi]\n",
      "AB  - Systemic sclerosis (SSc), also known as scleroderma, is an autoimmune disease \n",
      "      with multiple system involvement, and pulmonary complications, including \n",
      "      pulmonary hypertension (PH), are leading causes of death. This study aimed to \n",
      "      develop early biomarkers to distinguish SSc with or without PH from normal \n",
      "      population using bioinformatics approaches. The gene expression profile GSE22356, \n",
      "      which contains 10 SSc samples with PH, 10 SSc samples without PH, and 10 normal \n",
      "      samples, was obtained from the Gene Expression Omnibus database. First, we \n",
      "      constructed co-expression networks and identified critical gene modules using the \n",
      "      weighted gene co-expression network analysis. Then, functional enrichment \n",
      "      analysis of significant modules was performed. Finally, the \"real\" hub gene was \n",
      "      screened out by intramodule analysis and protein-protein interaction networks, \n",
      "      and the receiver operating characteristic analysis was conducted. A total of 5046 \n",
      "      genes were screened out to construct co-expression networks, and 18 modules were \n",
      "      identified. Of these modules, the turquoise module had a strong correlation with \n",
      "      SSc only, whereas the midnightblue module showed an obvious positive correlation \n",
      "      with SSc with PH. Functional enrichment analysis indicated that the turquoise \n",
      "      module was mainly enriched in transcription of DNA template and its regulation \n",
      "      and protein ubiquitination and involved in apoptosis and pyrimidine metabolism \n",
      "      pathway. The midnightblue module was significantly associated with inflammatory \n",
      "      and immune response and pathways in Staphylococcus aureus infection and Chagas \n",
      "      disease. The \"real\" hub genes in the turquoise module were WDR36, POLR1B, and \n",
      "      SRSF1, and those in midnightblue were TLR2 and TNFAIP6.\n",
      "FAU - Tang, Yiyang\n",
      "AU  - Tang Y\n",
      "AD  - Department of Cardiology, Xiangya Hospital, Central South University, Changsha, \n",
      "      People's Republic of China.\n",
      "FAU - Zha, Lihuang\n",
      "AU  - Zha L\n",
      "AD  - Department of Cardiology, Xiangya Hospital, Central South University, Changsha, \n",
      "      People's Republic of China.\n",
      "FAU - Zeng, Xiaofang\n",
      "AU  - Zeng X\n",
      "AD  - Department of Cardiology, Xiangya Hospital, Central South University, Changsha, \n",
      "      People's Republic of China.\n",
      "FAU - Yu, Zaixin\n",
      "AU  - Yu Z\n",
      "AD  - Department of Cardiology, Xiangya Hospital, Central South University, Changsha, \n",
      "      People's Republic of China.\n",
      "LA  - eng\n",
      "PT  - Journal Article\n",
      "PT  - Research Support, Non-U.S. Gov't\n",
      "DEP - 20200416\n",
      "PL  - United States\n",
      "TA  - J Comput Biol\n",
      "JT  - Journal of computational biology : a journal of computational molecular cell \n",
      "      biology\n",
      "JID - 9433358\n",
      "RN  - 0 (Cell Adhesion Molecules)\n",
      "RN  - 0 (Eye Proteins)\n",
      "RN  - 0 (Genetic Markers)\n",
      "RN  - 0 (SRSF1 protein, human)\n",
      "RN  - 0 (TLR2 protein, human)\n",
      "RN  - 0 (TNFAIP6 protein, human)\n",
      "RN  - 0 (Toll-Like Receptor 2)\n",
      "RN  - 0 (WDR36 protein, human)\n",
      "RN  - 170974-22-8 (Serine-Arginine Splicing Factors)\n",
      "RN  - EC 2.7.7.6 (DNA-Directed RNA Polymerases)\n",
      "RN  - EC 2.7.7.6 (POLR1B protein, human)\n",
      "SB  - IM\n",
      "MH  - Cell Adhesion Molecules/genetics\n",
      "MH  - Computational Biology\n",
      "MH  - DNA-Directed RNA Polymerases/genetics\n",
      "MH  - Databases, Genetic\n",
      "MH  - Eye Proteins/genetics\n",
      "MH  - Gene Regulatory Networks\n",
      "MH  - Genetic Markers\n",
      "MH  - Humans\n",
      "MH  - Hypertension, Pulmonary/*etiology/*genetics/metabolism\n",
      "MH  - Protein Interaction Maps/genetics\n",
      "MH  - Scleroderma, Systemic/*complications/*genetics/metabolism\n",
      "MH  - Serine-Arginine Splicing Factors/genetics\n",
      "MH  - Toll-Like Receptor 2/genetics\n",
      "MH  - Transcriptome\n",
      "OTO - NOTNLM\n",
      "OT  - biomarkers\n",
      "OT  - hub genes\n",
      "OT  - pulmonary hypertension\n",
      "OT  - systemic sclerosis\n",
      "OT  - weighted gene co-expression network analysis (WGCNA)\n",
      "EDAT- 2020/04/17 06:00\n",
      "MHDA- 2021/09/22 06:00\n",
      "CRDT- 2020/04/17 06:00\n",
      "PHST- 2020/04/17 06:00 [pubmed]\n",
      "PHST- 2021/09/22 06:00 [medline]\n",
      "PHST- 2020/04/17 06:00 [entrez]\n",
      "AID - 10.1089/cmb.2019.0492 [doi]\n",
      "PST - ppublish\n",
      "SO  - J Comput Biol. 2020 Oct;27(10):1519-1531. doi: 10.1089/cmb.2019.0492. Epub 2020 \n",
      "      Apr 16.\n",
      "\n",
      "PMID- 32244061\n",
      "OWN - NLM\n",
      "STAT- MEDLINE\n",
      "DCOM- 20201022\n",
      "LR  - 20201022\n",
      "IS  - 1879-2618 (Electronic)\n",
      "IS  - 1388-1981 (Linking)\n",
      "VI  - 1865\n",
      "IP  - 7\n",
      "DP  - 2020 Jul\n",
      "TI  - The WD40 repeat protein, WDR36, orchestrates sphingosine kinase-1 recruitment and \n",
      "      phospholipase C-beta activation by G(q)-coupled receptors.\n",
      "PG  - 158704\n",
      "LID - S1388-1981(20)30096-2 [pii]\n",
      "LID - 10.1016/j.bbalip.2020.158704 [doi]\n",
      "AB  - Sphingosine kinases (SphK) catalyse the formation of sphingosine-1-phosphate \n",
      "      (S1P) and play important roles in the cardiovascular, nervous and immune systems. \n",
      "      We have shown before that G(q)-coupled receptors induce a rapid and long-lasting \n",
      "      translocation of SphK1 to the plasma membrane and cross-activation of S1P \n",
      "      receptors. Here, we further addressed G(q) regulation of SphK1 by analysing the \n",
      "      influence of the WD40 repeat protein, WDR36. WDR36 has been described as a \n",
      "      scaffold tethering Galpha(q) to phospholipase C (PLC)-beta and the thromboxane A(2) \n",
      "      receptor-beta (TPbeta receptor). Overexpression of WDR36 in HEK-293 cells enhanced TPbeta \n",
      "      receptor-induced inositol phosphate production, as reported (Cartier et al. \n",
      "      2011), but significantly attenuated inositol phosphate production induced by \n",
      "      muscarinic M(3) and bradykinin B(2) receptors. In agreement with its effect on \n",
      "      PLCbeta, WDR36 augmented TPbeta receptor-induced [Ca(2+)](i) increases. Surprisingly, \n",
      "      WDR36 also augmented M(3) receptor-induced [Ca(2+)](i) increases, which was due \n",
      "      to increased Ca(2+) mobilization while the Ca(2+) content of \n",
      "      thapsigargin-sensitive stores remained unaltered. Interestingly, overexpression \n",
      "      of WDR36 significantly delayed SphK1 translocation by G(q)-coupled M(3), B(2) and \n",
      "      H(1) receptors in HEK-293 cells, while TPbeta receptor-induced SphK1 translocation \n",
      "      was generally slow and not altered by WDR36 in these cells. Finally, in C2C12 \n",
      "      myoblasts, overexpression of WDR36 delayed SphK1 translocation induced by B(2) \n",
      "      receptors. It is concluded that WDR36 reduces signalling of G(q)-coupled \n",
      "      receptors other than TPbeta towards PLC and SphK1, most likely by scavenging Galpha(q) \n",
      "      and PLCbeta. Our results support a role of WDR36 in orchestration of G(q) signalling \n",
      "      complexes, and might help to functionally unravel its genetic association with \n",
      "      asthma and allergy.\n",
      "CI  - Copyright (c) 2020 Elsevier B.V. All rights reserved.\n",
      "FAU - Blankenbach, Kira Vanessa\n",
      "AU  - Blankenbach KV\n",
      "AD  - Institut fur Allgemeine Pharmakologie und Toxikologie, Universitatsklinikum, \n",
      "      Goethe-Universitat, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. \n",
      "      Electronic address: kira.blankenbach@web.de.\n",
      "FAU - Bruno, Gennaro\n",
      "AU  - Bruno G\n",
      "AD  - Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Universita degli \n",
      "      Studi di Firenze, Viale Morgagni 50, 50134 Firenze, Italy. Electronic address: \n",
      "      gennaro.bruno@unifi.it.\n",
      "FAU - Wondra, Enrico\n",
      "AU  - Wondra E\n",
      "AD  - Institut fur Allgemeine Pharmakologie und Toxikologie, Universitatsklinikum, \n",
      "      Goethe-Universitat, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. \n",
      "      Electronic address: e.wondra@stud.uni-frankfurt.de.\n",
      "FAU - Spohner, Anna Katharina\n",
      "AU  - Spohner AK\n",
      "AD  - Institut fur Allgemeine Pharmakologie und Toxikologie, Universitatsklinikum, \n",
      "      Goethe-Universitat, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. \n",
      "      Electronic address: spohner@em.uni-frankfurt.de.\n",
      "FAU - Aster, Natalie Judith\n",
      "AU  - Aster NJ\n",
      "AD  - Institut fur Allgemeine Pharmakologie und Toxikologie, Universitatsklinikum, \n",
      "      Goethe-Universitat, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. \n",
      "      Electronic address: s5599083@stud.uni-frankfurt.de.\n",
      "FAU - Vienken, Hans\n",
      "AU  - Vienken H\n",
      "AD  - Institut fur Allgemeine Pharmakologie und Toxikologie, Universitatsklinikum, \n",
      "      Goethe-Universitat, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. \n",
      "      Electronic address: hansvienken@gmail.com.\n",
      "FAU - Trautmann, Sandra\n",
      "AU  - Trautmann S\n",
      "AD  - Institut fur Klinische Pharmakologie, Universitatsklinikum, Goethe-Universitat, \n",
      "      Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. Electronic address: \n",
      "      trautmann@med.uni-frankfurt.de.\n",
      "FAU - Ferreiros, Nerea\n",
      "AU  - Ferreiros N\n",
      "AD  - Institut fur Klinische Pharmakologie, Universitatsklinikum, Goethe-Universitat, \n",
      "      Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. Electronic address: \n",
      "      ferreirosbouzas@em.uni-frankfurt.de.\n",
      "FAU - Wieland, Thomas\n",
      "AU  - Wieland T\n",
      "AD  - Experimentelle Pharmakologie, Medizinische Fakultat Mannheim der Universitat \n",
      "      Heidelberg, Ludolf Krehl-Str. 13-17, D-68167 Mannheim, Germany. Electronic \n",
      "      address: thomas.wieland@medma.uni-heidelberg.de.\n",
      "FAU - Bruni, Paola\n",
      "AU  - Bruni P\n",
      "AD  - Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Universita degli \n",
      "      Studi di Firenze, Viale Morgagni 50, 50134 Firenze, Italy. Electronic address: \n",
      "      paola.bruni@unifi.it.\n",
      "FAU - Meyer Zu Heringdorf, Dagmar\n",
      "AU  - Meyer Zu Heringdorf D\n",
      "AD  - Institut fur Allgemeine Pharmakologie und Toxikologie, Universitatsklinikum, \n",
      "      Goethe-Universitat, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. \n",
      "      Electronic address: heringdorf@med.uni-frankfurt.de.\n",
      "LA  - eng\n",
      "PT  - Journal Article\n",
      "PT  - Research Support, Non-U.S. Gov't\n",
      "DEP - 20200331\n",
      "PL  - Netherlands\n",
      "TA  - Biochim Biophys Acta Mol Cell Biol Lipids\n",
      "JT  - Biochimica et biophysica acta. Molecular and cell biology of lipids\n",
      "JID - 101731727\n",
      "RN  - 0 (Eye Proteins)\n",
      "RN  - 0 (Receptors, Thromboxane)\n",
      "RN  - 0 (WDR36 protein, mouse)\n",
      "RN  - EC 2.7.1.- (Phosphotransferases (Alcohol Group Acceptor))\n",
      "RN  - EC 2.7.1.- (Sphk1 protein, mouse)\n",
      "RN  - EC 3.1.4.11 (Phospholipase C beta)\n",
      "RN  - EC 3.6.5.1 (GTP-Binding Protein alpha Subunits, Gq-G11)\n",
      "RN  - SY7Q814VUP (Calcium)\n",
      "SB  - IM\n",
      "MH  - Animals\n",
      "MH  - Calcium/metabolism\n",
      "MH  - Eye Proteins/genetics/*metabolism\n",
      "MH  - GTP-Binding Protein alpha Subunits, Gq-G11/metabolism\n",
      "MH  - HEK293 Cells\n",
      "MH  - Humans\n",
      "MH  - Mice\n",
      "MH  - Myoblasts/metabolism\n",
      "MH  - Phospholipase C beta/*metabolism\n",
      "MH  - Phosphotransferases (Alcohol Group Acceptor)/*metabolism\n",
      "MH  - Receptors, Thromboxane/*metabolism\n",
      "MH  - *Signal Transduction\n",
      "OTO - NOTNLM\n",
      "OT  - Ca(2+) signalling\n",
      "OT  - G(q)\n",
      "OT  - G-protein-coupled receptors\n",
      "OT  - Phospholipase C\n",
      "OT  - Sphingosine kinase\n",
      "OT  - WDR36\n",
      "EDAT- 2020/04/04 06:00\n",
      "MHDA- 2020/10/23 06:00\n",
      "CRDT- 2020/04/04 06:00\n",
      "PHST- 2019/10/04 00:00 [received]\n",
      "PHST- 2020/03/13 00:00 [revised]\n",
      "PHST- 2020/03/27 00:00 [accepted]\n",
      "PHST- 2020/04/04 06:00 [pubmed]\n",
      "PHST- 2020/10/23 06:00 [medline]\n",
      "PHST- 2020/04/04 06:00 [entrez]\n",
      "AID - S1388-1981(20)30096-2 [pii]\n",
      "AID - 10.1016/j.bbalip.2020.158704 [doi]\n",
      "PST - ppublish\n",
      "SO  - Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Jul;1865(7):158704. doi: \n",
      "      10.1016/j.bbalip.2020.158704. Epub 2020 Mar 31.\n",
      "\n",
      "PMID- 32082391\n",
      "OWN - NLM\n",
      "STAT- PubMed-not-MEDLINE\n",
      "LR  - 20220412\n",
      "IS  - 1710-1484 (Print)\n",
      "IS  - 1710-1492 (Electronic)\n",
      "IS  - 1710-1484 (Linking)\n",
      "VI  - 16\n",
      "DP  - 2020\n",
      "TI  - Replication study of susceptibility variants associated with allergic rhinitis \n",
      "      and allergy in Han Chinese.\n",
      "PG  - 13\n",
      "LID - 10.1186/s13223-020-0411-9 [doi]\n",
      "LID - 13\n",
      "AB  - BACKGROUND: Allergic rhinitis (AR) is believed to be a complex genetic disease. \n",
      "      The last decade has been marked by the publication of more than 20 genome-wide \n",
      "      association studies (GWASs) of AR and associated allergic phenotypes and allergic \n",
      "      diseases, which have shown allergic diseases and traits to share a large number \n",
      "      of genetic susceptibility loci. The aim of present study was therefore to \n",
      "      investigate the highly replicated allergy related genes and variants as \n",
      "      candidates for AR in Han Chinese subjects. METHODS: A total of 762 AR patients \n",
      "      and 760 control subjects were recruited, and a total of 58 susceptible variants \n",
      "      previously reported to be associated with allergic traits were choose for \n",
      "      replication. RESULTS: Logistic regression analyses revealed that in the \n",
      "      co-dominant-effect model as assessed by the AIC, compared with wild-type \n",
      "      carriers, significant AR risk were associated with rs9865818 in LPP (P = 0.029, \n",
      "      OR = 1.469 for GG vs. AA); rs6554809 in DNAH5 (P = 0.000, OR = 1.597 for TC vs. \n",
      "      CC); rs1438673 in WDR36-CAMK4 loci (P = 0.037, OR = 1.396 for CC vs.TT), \n",
      "      rs7775228 in HLA region (P = 0.000, OR = 1.589 for TC vs.TT), rs7203459 in \n",
      "      CLEC16A (P = 0.025, OR = 0.731 for TC vs. TT). CONCLUSION: We replicated Han \n",
      "      Chinese AR-specific susceptibility loci in LPP, DNAH5, HLA, CLEC16A and \n",
      "      WDR36-CAMK4. Further understanding the molecular mechanisms underlying these \n",
      "      associations may provide new insights into the etiology of allergic disease.\n",
      "CI  - (c) The Author(s) 2020.\n",
      "FAU - Gao, Yunbo\n",
      "AU  - Gao Y\n",
      "AD  - 1Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, \n",
      "      Capital Medical University, Beijing, 100730 People's Republic of China. ISNI: \n",
      "      0000 0004 0369 153X. GRID: grid.24696.3f\n",
      "FAU - Li, Jingyun\n",
      "AU  - Li J\n",
      "AD  - 1Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, \n",
      "      Capital Medical University, Beijing, 100730 People's Republic of China. ISNI: \n",
      "      0000 0004 0369 153X. GRID: grid.24696.3f\n",
      "AD  - 2Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, \n",
      "      No. 17, HouGouHuTong, DongCheng District, Beijing, 100005 People's Republic of \n",
      "      China. ISNI: 0000 0004 1758 1243. GRID: grid.414373.6\n",
      "FAU - Zhang, Yuan\n",
      "AU  - Zhang Y\n",
      "AD  - 1Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, \n",
      "      Capital Medical University, Beijing, 100730 People's Republic of China. ISNI: \n",
      "      0000 0004 0369 153X. GRID: grid.24696.3f\n",
      "AD  - 2Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, \n",
      "      No. 17, HouGouHuTong, DongCheng District, Beijing, 100005 People's Republic of \n",
      "      China. ISNI: 0000 0004 1758 1243. GRID: grid.414373.6\n",
      "AD  - 3Department of Allergy, Beijing TongRen Hospital, Capital Medical University, \n",
      "      Beijing, 100730 People's Republic of China. ISNI: 0000 0004 0369 153X. GRID: \n",
      "      grid.24696.3f\n",
      "FAU - Zhang, Luo\n",
      "AU  - Zhang L\n",
      "AUID- ORCID: 0000-0002-0910-9884\n",
      "AD  - 1Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, \n",
      "      Capital Medical University, Beijing, 100730 People's Republic of China. ISNI: \n",
      "      0000 0004 0369 153X. GRID: grid.24696.3f\n",
      "AD  - 2Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, \n",
      "      No. 17, HouGouHuTong, DongCheng District, Beijing, 100005 People's Republic of \n",
      "      China. ISNI: 0000 0004 1758 1243. GRID: grid.414373.6\n",
      "AD  - 3Department of Allergy, Beijing TongRen Hospital, Capital Medical University, \n",
      "      Beijing, 100730 People's Republic of China. ISNI: 0000 0004 0369 153X. GRID: \n",
      "      grid.24696.3f\n",
      "LA  - eng\n",
      "PT  - Journal Article\n",
      "DEP - 20200211\n",
      "PL  - England\n",
      "TA  - Allergy Asthma Clin Immunol\n",
      "JT  - Allergy, asthma, and clinical immunology : official journal of the Canadian \n",
      "      Society of Allergy and Clinical Immunology\n",
      "JID - 101244313\n",
      "PMC - PMC7014941\n",
      "OTO - NOTNLM\n",
      "OT  - Allergic rhinitis\n",
      "OT  - Replication\n",
      "OT  - Single nucleotide polymorphism\n",
      "COIS- Competing interestsThe authors declare that they have no competing interests.\n",
      "EDAT- 2020/02/23 06:00\n",
      "MHDA- 2020/02/23 06:01\n",
      "CRDT- 2020/02/22 06:00\n",
      "PHST- 2019/10/18 00:00 [received]\n",
      "PHST- 2020/01/28 00:00 [accepted]\n",
      "PHST- 2020/02/22 06:00 [entrez]\n",
      "PHST- 2020/02/23 06:00 [pubmed]\n",
      "PHST- 2020/02/23 06:01 [medline]\n",
      "AID - 411 [pii]\n",
      "AID - 10.1186/s13223-020-0411-9 [doi]\n",
      "PST - epublish\n",
      "SO  - Allergy Asthma Clin Immunol. 2020 Feb 11;16:13. doi: 10.1186/s13223-020-0411-9. \n",
      "      eCollection 2020.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "\n",
    "# Pesquisa para o gene \n",
    "search_query = \"WDR36[Gene]\"\n",
    "article_ids = search_pubmed(search_query)\n",
    "\n",
    "if article_ids:\n",
    "    # Obter os registros dos artigos\n",
    "    pubmed_records = fetch_pubmed_articles(article_ids)\n",
    "    print(pubmed_records)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
